|
|
(01) Behavior, Behavioral Change, and Prevention
Topics in the table below that are marked with an asterisk (*) have been designated as the Institute, Center or Office’s highest priority; however, applicants may apply to any of the topics.
| Challenge Topic ID |
Specific Challenge Topic |
Contact |
| 01-OD-101* |
Test default options to promote healthier behaviors. Exploration by behavioral economists and clinicians to develop and test default options (e.g., placement of fresh fruit displays in stores, the location of parking spaces at the workplace) to promote healthier behaviors. |
Dr. Jonathan King (NIA)
301-402-4156
kingjo@mail.nih.gov |
| 01-OD-102 |
Innovative Approaches to Improve Patient and Provider Adherence. Both poor patient adherence to prescribed medical regimens and poor utilization of adherence-enhancing strategies in clinical practice severely limit the public health impact of efficacious treatments and preventive regimens. The challenge is to integrate and improve existing technologies to improve patient self-monitoring, provide automatic reminders, and link service providers, patients, and pharmacies through electronic medical records. These technologies will allow the rapid identification of probable patient non-adherence and will help clinicians generate individualized treatment plans that could enhance patient outcomes. |
Dr. Lynn Bosco (OD/OBSSR)
301-451-4286
boscol@od.nih.gov |
| 01-OD-103 |
Methodologies or technologies that facilitate understanding of the biological effects of behavioral interventions. The ability to modify behavior is critical for preventing, managing and treating many important health conditions. Approaches are needed that will identify, quantify, and document biological changes associated with initiation and maintenance of human behavior change. |
Dr. Lisa Onken (NIDA)
301-443-2235
lonken@mail.nih.gov |
| 01-OD-104 |
Mechanisms of Behavior Change. The challenge is to identify mechanisms and controllable variables that underlie positive change in health behaviors. This will require use of models that incorporate and relate findings at different levels of analysis from the genomic through the physiologic to the psychological and social. |
Dr. Mark Willenbring (NIAAA)
301-443-1208
mlw@niaaa.nih.gov |
Up to Top
|
